90.81
前日終値:
$91.60
開ける:
$90.84
24時間の取引高:
2.25M
Relative Volume:
0.47
時価総額:
$52.34B
収益:
$6.30B
当期純損益:
$1.07B
株価収益率:
49.34
EPS:
1.8406
ネットキャッシュフロー:
$1.09B
1週間 パフォーマンス:
-1.33%
1か月 パフォーマンス:
+5.93%
6か月 パフォーマンス:
+15.76%
1年 パフォーマンス:
+16.04%
Edwards Lifesciences Corp Stock (EW) Company Profile
名前
Edwards Lifesciences Corp
セクター
電話
(949) 250-2500
住所
ONE EDWARDS WAY, IRVINE, CA
Compare EW vs ABT, SYK, MDT, BSX
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
|
EW
Edwards Lifesciences Corp
|
90.81 | 52.80B | 6.30B | 1.07B | 1.09B | 1.8406 |
|
ABT
Abbott Laboratories
|
110.37 | 192.51B | 46.59B | 5.41B | 7.38B | 3.0938 |
|
SYK
Stryker Corp
|
331.68 | 130.11B | 25.27B | 3.34B | 4.57B | 8.6334 |
|
MDT
Medtronic Plc
|
90.60 | 116.83B | 36.36B | 4.84B | 5.43B | 3.7261 |
|
BSX
Boston Scientific Corp
|
51.43 | 75.11B | 20.62B | 3.56B | 3.48B | 2.3847 |
Edwards Lifesciences Corp Stock (EW) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2026-04-01 | アップグレード | Wolfe Research | Peer Perform → Outperform |
| 2026-01-09 | アップグレード | TD Cowen | Hold → Buy |
| 2025-12-18 | アップグレード | JP Morgan | Neutral → Overweight |
| 2025-11-03 | アップグレード | Raymond James | Mkt Perform → Outperform |
| 2025-10-29 | アップグレード | Jefferies | Hold → Buy |
| 2025-10-29 | アップグレード | Wolfe Research | Underperform → Peer Perform |
| 2025-10-08 | ダウングレード | Oppenheimer | Outperform → Perform |
| 2025-10-07 | アップグレード | Evercore ISI | In-line → Outperform |
| 2025-07-29 | アップグレード | BTIG Research | Neutral → Buy |
| 2025-04-24 | アップグレード | Piper Sandler | Neutral → Overweight |
| 2025-01-30 | アップグレード | Stifel | Hold → Buy |
| 2025-01-16 | ダウングレード | Wolfe Research | Peer Perform → Underperform |
| 2024-12-16 | アップグレード | BofA Securities | Neutral → Buy |
| 2024-10-11 | 再開されました | Morgan Stanley | Equal-Weight |
| 2024-09-18 | ダウングレード | Jefferies | Buy → Hold |
| 2024-07-31 | アップグレード | Daiwa Securities | Neutral → Outperform |
| 2024-07-29 | アップグレード | Wolfe Research | Underperform → Peer Perform |
| 2024-07-25 | ダウングレード | BofA Securities | Buy → Neutral |
| 2024-07-25 | ダウングレード | JP Morgan | Overweight → Neutral |
| 2024-07-25 | ダウングレード | Robert W. Baird | Outperform → Neutral |
| 2024-07-25 | ダウングレード | TD Cowen | Buy → Hold |
| 2024-07-25 | ダウングレード | Truist | Buy → Hold |
| 2024-05-30 | 開始されました | Goldman | Buy |
| 2024-05-22 | アップグレード | Citigroup | Neutral → Buy |
| 2024-05-14 | アップグレード | Deutsche Bank | Hold → Buy |
| 2024-03-07 | アップグレード | BofA Securities | Neutral → Buy |
| 2024-02-02 | アップグレード | Wells Fargo | Equal Weight → Overweight |
| 2024-01-04 | ダウングレード | Evercore ISI | Outperform → In-line |
| 2023-12-11 | ダウングレード | Citigroup | Buy → Neutral |
| 2023-11-28 | ダウングレード | Wolfe Research | Peer Perform → Underperform |
| 2023-09-26 | アップグレード | Oppenheimer | Perform → Outperform |
| 2023-07-19 | 開始されました | Robert W. Baird | Outperform |
| 2023-05-30 | 再開されました | Morgan Stanley | Overweight |
| 2023-03-29 | 開始されました | UBS | Neutral |
| 2023-03-08 | ダウングレード | Wells Fargo | Overweight → Equal Weight |
| 2023-02-06 | ダウングレード | Raymond James | Outperform → Mkt Perform |
| 2023-01-31 | ダウングレード | Bernstein | Outperform → Underperform |
| 2023-01-30 | ダウングレード | Piper Sandler | Overweight → Neutral |
| 2022-12-06 | ダウングレード | Stifel | Buy → Hold |
| 2022-10-28 | ダウングレード | Oppenheimer | Outperform → Perform |
| 2022-10-26 | 開始されました | Mizuho | Buy |
| 2022-10-18 | 開始されました | Barclays | Overweight |
| 2022-10-12 | 開始されました | Jefferies | Buy |
| 2022-07-29 | ダウングレード | Canaccord Genuity | Buy → Hold |
| 2022-04-13 | 開始されました | Truist | Buy |
| 2022-04-06 | 開始されました | Wolfe Research | Outperform |
| 2022-03-16 | アップグレード | Bernstein | Mkt Perform → Outperform |
| 2022-03-02 | 再開されました | BofA Securities | Neutral |
| 2022-02-02 | アップグレード | UBS | Neutral → Buy |
| 2022-01-27 | 繰り返されました | Citigroup | Buy |
| 2022-01-27 | 繰り返されました | Evercore ISI | Outperform |
| 2022-01-27 | 繰り返されました | Raymond James | Outperform |
| 2022-01-27 | 繰り返されました | Stifel | Buy |
| 2022-01-27 | 繰り返されました | UBS | Neutral |
| 2021-12-17 | アップグレード | JP Morgan | Neutral → Overweight |
| 2021-12-15 | アップグレード | Citigroup | Neutral → Buy |
| 2021-12-10 | 開始されました | RBC Capital Mkts | Outperform |
| 2021-12-06 | アップグレード | Wells Fargo | Equal Weight → Overweight |
| 2021-07-30 | 繰り返されました | Canaccord Genuity | Buy |
| 2021-07-30 | 繰り返されました | Deutsche Bank | Hold |
| 2021-07-30 | 繰り返されました | Jefferies | Buy |
| 2021-07-30 | 繰り返されました | Morgan Stanley | Overweight |
| 2021-07-30 | 繰り返されました | Oppenheimer | Outperform |
| 2021-07-30 | 繰り返されました | Stifel | Buy |
| 2021-07-30 | 繰り返されました | UBS | Neutral |
| 2021-07-30 | 繰り返されました | Wells Fargo | Equal Weight |
| 2021-05-25 | 開始されました | Barclays | Overweight |
| 2021-04-15 | 開始されました | Atlantic Equities | Neutral |
| 2021-04-05 | アップグレード | Evercore ISI | In-line → Outperform |
| 2020-12-16 | ダウングレード | Citigroup | Buy → Neutral |
| 2020-12-11 | 繰り返されました | Canaccord Genuity | Buy |
| 2020-09-11 | 開始されました | Wolfe Research | Underperform |
| 2020-04-28 | ダウングレード | Wells Fargo | Overweight → Equal Weight |
| 2020-04-17 | アップグレード | SVB Leerink | Mkt Perform → Outperform |
| 2020-03-05 | 開始されました | Citigroup | Buy |
| 2020-02-13 | 開始されました | Goldman | Neutral |
| 2020-02-06 | 再開されました | BTIG Research | Neutral |
| 2020-01-10 | 開始されました | Oppenheimer | Outperform |
| 2020-01-02 | ダウングレード | Evercore ISI | Outperform → In-line |
| 2019-10-24 | 繰り返されました | Canaccord Genuity | Buy |
| 2019-09-23 | 開始されました | Piper Jaffray | Overweight |
| 2019-07-24 | 繰り返されました | BofA/Merrill | Buy |
| 2019-03-18 | 繰り返されました | Canaccord Genuity | Buy |
| 2019-01-18 | アップグレード | BofA/Merrill | Neutral → Buy |
| 2019-01-03 | 開始されました | Deutsche Bank | Hold |
| 2018-11-28 | 開始されました | UBS | Neutral |
| 2018-10-16 | 開始されました | Barclays | Underweight |
| 2018-10-02 | ダウングレード | BofA/Merrill | Buy → Neutral |
| 2018-10-02 | ダウングレード | Guggenheim | Buy → Neutral |
すべてを表示
Edwards Lifesciences Corp (EW) 最新ニュース
Oppenheimer Asset Management Inc. Purchases Shares of 22,090 Edwards Lifesciences Corporation $EW - marketbeat.com
AMG National Trust Bank Invests $6.83 Million in Edwards Lifesciences Corporation $EW - marketbeat.com
Maridea Wealth Management LLC Purchases New Position in Edwards Lifesciences Corporation $EW - marketbeat.com
Bank Hapoalim BM Makes New $1.78 Million Investment in Edwards Lifesciences Corporation $EW - marketbeat.com
Empowered Funds LLC Boosts Stock Position in Edwards Lifesciences Corporation $EW - marketbeat.com
ABN AMRO Bank N.V. Makes New $83.57 Million Investment in Edwards Lifesciences Corporation $EW - marketbeat.com
Everett Harris & Co. CA Acquires Shares of 80,341 Edwards Lifesciences Corporation $EW - marketbeat.com
Edwards Lifesciences Corp. stock underperforms Friday when compared to competitors - MarketWatch
EW|Edwards Lifesciences Corp|Price:90.865|Chg%:-0.735 - TradingKey
Seascape Capital Management's Edwards Lifesciences Corp(EW) Holding History - GuruFocus
Is Wall Street Bullish or Bearish on Edwards Lifesciences Stock? - finance.yahoo.com
Edwards Lifesciences CVP sells $56,966 in company stock By Investing.com - Investing.com Australia
Edwards Lifesciences CVP sells $56,966 in company stock - Investing.com
Edwards Lifesciences (EW) Insider Daniel Lippis Sells 619 Shares - GuruFocus
EW News | EDWARDS LIFESCIENCES CORP (NYSE:EW) - ChartMill
Daniel Lippis Sells 619 Shares of Edwards Lifesciences (NYSE:EW) Stock - MarketBeat
Edwards Lifesciences Corp. stock outperforms competitors on strong trading day - MarketWatch
Edwards Lifesciences (EW) insider files Form 144 for cashless option exercise - Stock Titan
Handelsbanken Fonder AB Has $139.42 Million Holdings in Edwards Lifesciences Corporation $EW - MarketBeat
29,000 Shares in Edwards Lifesciences Corporation $EW Bought by Renaissance Technologies LLC - marketbeat.com
Edwards Lifesciences Corporation $EW is Seilern Investment Management Ltd's 4th Largest Position - marketbeat.com
Orser Capital Management LLC Invests $2.32 Million in Edwards Lifesciences Corporation $EW - marketbeat.com
Assenagon Asset Management S.A. Acquires 547,212 Shares of Edwards Lifesciences Corporation $EW - MarketBeat
Edwards Lifesciences Corporation (NYSE:EW) Given Consensus Rating of "Moderate Buy" by Analysts - marketbeat.com
Fund Update: 525,889 EDWARDS LIFESCIENCES (EW) shares added to ABN AMRO Bank N.V. portfolio - Quiver Quantitative
Segall Bryant & Hamill LLC Acquires New Stake in Edwards Lifesciences Corporation $EW - MarketBeat
EW CLASS ACTION FINAL DEADLINE: Edwards Lifesciences Investors are Notified that Today is the Final Deadline in Securities Fraud Class Action and are Urged to Contact BFA Law - TMX Newsfile
Edwards Lifesciences (EW) Has a Growth Runway Competitors May Struggle to Match - Yahoo Finance
Is It Too Late to Buy Edwards Lifesciences Corp (EW) After 3.2% Rally? GF Value Says Undervalued - GuruFocus
Bank of America Corp DE Acquires 2,212,208 Shares of Edwards Lifesciences Corporation $EW - marketbeat.com
Groupama Asset Managment Purchases New Position in Edwards Lifesciences Corporation $EW - marketbeat.com
Empowered Funds LLC Increases Holdings in Edwards Lifesciences Corporation $EW - marketbeat.com
California State Teachers Retirement System Sells 34,344 Shares of Edwards Lifesciences Corporation $EW - MarketBeat
Liontrust Investment Partners LLP Trims Stock Position in Edwards Lifesciences Corporation $EW - marketbeat.com
Form 4 Edwards Lifesciences Corp For: 30 July By Investing.com - Investing.com Canada
Edwards Lifesciences Corp. stock rises Thursday, still underperforms market - MarketWatch
Edwards Lifesciences CVP Markowitz sells $12,587 of company stock - Investing.com
Edwards Lifesciences Corporation $EW Holdings Lifted by First Trust Advisors LP - marketbeat.com
UBS initiates Edwards Lifesciences stock coverage with buy rating By Investing.com - Investing.com Nigeria
UBS Group Begins Coverage on Edwards Lifesciences (NYSE:EW) - marketbeat.com
Form 4 Edwards Lifesciences Corp For: 27 July By Investing.com - Investing.com Nigeria
Edwards Lifesciences CEO Bernard Zovighian sells $245,134 in shares - Investing.com
Form 144 Edwards Lifesciences Corp For: 27 July By Investing.com - Investing.com South Africa
Form 144 Edwards Lifesciences Corp For: 27 July - Investing.com India
EW|Edwards Lifesciences Corp|Price:83.040|Chg%:+0.410 - TradingKey
Edwards Lifesciences (EW)’s TMTT Revenue Surges 47%: Can Rapid Growth Drive the Next Leg of Earnings Expansion? - Yahoo Finance Singapore
Edwards Lifesciences (EW) insider Zovighian details recent $2.83M stock sale in Form 144 - Stock Titan
Edwards Lifesciences Corp (EW) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Edwards Lifesciences stock trades steady as TAVR growth supports margins - Ad-hoc-news.de
Edwards Lifesciences Corporation $EW Shares Purchased by Arrowstreet Capital Limited Partnership - marketbeat.com
ETFs Investing in Edwards Lifesciences Corporation Stocks - TradingView
Edwards Lifesciences Corp (EW) 財務データ
収益
当期純利益
現金流量
EPS
大文字化:
|
ボリューム (24 時間):